PEGylation for enhancing nanoparticle diffusion in mucus☆
暂无分享,去创建一个
[1] F. Campbell,et al. Study of human precorneal tear film thickness and structure using laser interferometry. , 1992, Investigative ophthalmology & visual science.
[2] Claus-Michael Lehr,et al. Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus , 2012, Proceedings of the National Academy of Sciences.
[3] Clive J Roberts,et al. Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. , 2002, Bioconjugate chemistry.
[4] P. G. de Gennes,et al. Conformations of Polymers Attached to an Interface , 1980 .
[5] Ali Akbar Pourfatollah,et al. Various methods of gold nanoparticles (GNPs) conjugation to antibodies , 2016 .
[6] R Weltzin,et al. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting , 1996, The Journal of experimental medicine.
[7] Andrew Emili,et al. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. , 2012, Journal of the American Chemical Society.
[8] G. P. Martin,et al. Anti-mucus polyclonal antibody production, purification and linkage to the surface of albumin microspheres. , 2000, International journal of pharmaceutics.
[9] O. Danos,et al. Intranasal gene delivery with a polyethylenimine-PEG conjugate. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[10] V. Korolik,et al. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. , 2007, The Journal of clinical investigation.
[11] M. Wirth,et al. Lectin-mediated bioadhesion: Proteolytic stability and binding-characteristics of wheat germ agglutinin and Solanum tuberosum lectin on Caco-2, HT-29 and human colonocytes , 1997 .
[12] Y. Kawashima,et al. Mucoadhesive nanoparticulate systems for peptide drug delivery. , 2001, Advanced drug delivery reviews.
[13] Samuel K. Lai,et al. Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-co-glycolic acid) , 2011, Drug Delivery and Translational Research.
[14] Yen Cu,et al. Mathematical modeling of molecular diffusion through mucus. , 2009, Advanced drug delivery reviews.
[15] C. Cai,et al. "Clickable", polymerized liposomes as a versatile and stable platform for rapid optimization of their peripheral compositions. , 2010, Chemical communications.
[16] R. Langer,et al. Drug delivery and targeting. , 1998, Nature.
[17] N. Peppas,et al. Oral delivery of insulin using pH-responsive complexation gels. , 1999, Journal of pharmaceutical sciences.
[18] J. Irache,et al. Bioadhesion of Lectin-Latex Conjugates to Rat Intestinal Mucosa , 1996, Pharmaceutical Research.
[19] Claus-Michael Lehr,et al. Bioadhesion by Means of Specific Binding of Tomato Lectin , 1992, Pharmaceutical Research.
[20] M. Chilvers,et al. Local mucociliary defence mechanisms. , 2000, Paediatric respiratory reviews.
[21] J. Suh,et al. Gene Delivery to the Lung , 2003 .
[22] D. Fischer,et al. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives , 2005, The journal of gene medicine.
[23] David J Brayden,et al. In Vitro and ex Vivo Intestinal Tissue Models to Measure Mucoadhesion of Poly (Methacrylate) and N-Trimethylated Chitosan Polymers , 2004, Pharmaceutical Research.
[24] X. Banquy,et al. Assessment of PEG on polymeric particles surface, a key step in drug carrier translation. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[25] N A Peppas,et al. Surface modifications and molecular imprinting of polymers in medical and pharmaceutical applications. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[26] J. Robinson,et al. Some biological issues in oral, controlled drug delivery , 1987 .
[27] A. I. Yudin,et al. Diffusion of macromolecules and virus-like particles in human cervical mucus. , 2001, Biophysical journal.
[28] Elizabeth Nance,et al. A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue , 2012, Science Translational Medicine.
[29] Anthony P Corfield,et al. Mucins: a biologically relevant glycan barrier in mucosal protection. , 2015, Biochimica et biophysica acta.
[30] Benjamin C. Tang,et al. Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier , 2009, Proceedings of the National Academy of Sciences.
[31] N. Peppas,et al. Poly(ethylene glycol)-containing hydrogels in drug delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[32] N. Rigby,et al. Lamellar structures of MUC2-rich mucin: a potential role in governing the barrier and lubricating functions of intestinal mucus. , 2012, Biomacromolecules.
[33] Mark E. Davis,et al. PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. , 2004, European journal of cell biology.
[34] M. Knowles,et al. Mucus clearance as a primary innate defense mechanism for mammalian airways. , 2002, The Journal of clinical investigation.
[35] Benjamin C. Tang,et al. Vaginal Delivery of Paclitaxel via Nanoparticles with Non‐Mucoadhesive Surfaces Suppresses Cervical Tumor Growth , 2014, Advanced healthcare materials.
[36] Denis Wirtz,et al. Micro- and macrorheology of mucus. , 2009, Advanced drug delivery reviews.
[37] Robert Langer,et al. Microfluidic platform for controlled synthesis of polymeric nanoparticles. , 2008, Nano letters.
[38] S. Muro,et al. Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice , 2012, International journal of nanomedicine.
[39] D. Leckband,et al. Direct Measurement of Interactions between Tethered Poly(ethylene glycol) Chains and Adsorbed Mucin Layers , 2002 .
[40] Zhirong Zhang,et al. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[41] U. Schubert,et al. Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives. , 2011 .
[42] J. Irache,et al. Bioadhesive properties of pegylated nanoparticles , 2005, Expert opinion on drug delivery.
[43] M. Alonso,et al. The potential of chitosan for the oral administration of peptides , 2005, Expert opinion on drug delivery.
[44] Jin Chang,et al. PLGA/polymeric liposome for targeted drug and gene co-delivery. , 2010, Biomaterials.
[45] Laura M Ensign,et al. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. , 2016, Advanced drug delivery reviews.
[46] R. Emanuele. FLOCOR: a new anti-adhesive, rheologic agent. , 1998, Expert opinion on investigational drugs.
[47] Laura M Ensign,et al. Nanoparticles coated with high molecular weight PEG penetrate mucus and provide uniform vaginal and colorectal distribution in vivo. , 2016, Nanomedicine.
[48] Laura M Ensign,et al. Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues. , 2013, Molecular pharmaceutics.
[49] Laura M Ensign,et al. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. , 2012, Advanced drug delivery reviews.
[50] Justin Hanes,et al. A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[51] J. S. Suk,et al. Highly compacted DNA nanoparticles with low MW PEG coatings: in vitro, ex vivo and in vivo evaluation. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[52] S. Lai,et al. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus. , 2016, Acta biomaterialia.
[53] Scott H Randell,et al. Effective mucus clearance is essential for respiratory health. , 2006, American journal of respiratory cell and molecular biology.
[54] C. Lehr,et al. Lectin-mediated drug targeting: history and applications. , 2004, Advanced drug delivery reviews.
[55] D. Bush,et al. Twenty-four hour ambulatory nasal pH monitoring. , 2001, Clinical otolaryngology and allied sciences.
[56] Sarah L. Kieweg,et al. Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery. , 2006, Journal of biomechanical engineering.
[57] S. Kerss,et al. A simple method for measuring thickness of the mucus gel layer adherent to rat, frog and human gastric mucosa: influence of feeding, prostaglandin, N-acetylcysteine and other agents. , 1982, Clinical science.
[58] Si-Shen Feng,et al. Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery. , 2007, Biomaterials.
[59] T. Kararli. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.
[60] D. Roopenian,et al. Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection , 2011, Proceedings of the National Academy of Sciences.
[61] D. Schaffer,et al. PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization. , 2005, Biotechnology and bioengineering.
[62] Todd M. Allen,et al. Protection of Humanized Mice From Repeated Intravaginal HIV Challenge by Passive Immunization: A Model for Studying the Efficacy of Neutralizing Antibodies In Vivo. , 2016, Journal of Infectious Diseases.
[63] R. N. Palumbo,et al. Bacterial invasin: structure, function, and implication for targeted oral gene delivery. , 2006, Current drug delivery.
[64] A. Bernkop‐Schnürch. Mucoadhesive systems in oral drug delivery. , 2005, Drug discovery today. Technologies.
[65] Nicholas A Peppas,et al. Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[66] H. Griesser,et al. Electrostatic self-assembly of PEG copolymers onto porous silica nanoparticles. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[67] K. Ulbrich,et al. Multifunctional cytotoxic stealth nanoparticles. A model approach with potential for cancer therapy. , 2009, Nano letters.
[68] Yen Cu,et al. Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus. , 2009, Molecular pharmaceutics.
[69] T. Behnke,et al. Quantification of PEG-maleimide ligands and coupling efficiencies on nanoparticles with Ellman's reagent. , 2015, Analytical chemistry.
[70] R. Edlich,et al. Pluronic F-68: a promising new skin wound cleanser. , 1980, Annals of emergency medicine.
[71] Tian Xia,et al. Physicochemical properties determine nanomaterial cellular uptake, transport, and fate. , 2013, Accounts of chemical research.
[72] E. Åkerblom,et al. Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins. , 1983, International archives of allergy and applied immunology.
[73] J. Sheehan,et al. Structure and macromolecular properties of cervical mucus glycoproteins. , 1989, Symposia of the Society for Experimental Biology.
[74] P. Fong,et al. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[75] Samuel K. Lai,et al. IgG in cervicovaginal mucus traps HSV and prevents vaginal Herpes infections , 2014, Mucosal Immunology.
[76] D. Thornton,et al. From mucins to mucus: toward a more coherent understanding of this essential barrier. , 2004, Proceedings of the American Thoracic Society.
[77] A. Allen,et al. Gastroduodenal mucosal protection. , 1993, Physiological reviews.
[78] Si-Shen Feng,et al. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. , 2006, Biomaterials.
[79] T. Bhowmick,et al. Transport of nanocarriers across gastrointestinal epithelial cells by a new transcellular route induced by targeting ICAM-1. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[80] I. Gipson. Mucins of the human endocervix. , 2001, Frontiers in bioscience : a journal and virtual library.
[81] K. Whaley,et al. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. , 2001, Human reproduction.
[82] E. Mathiowitz,et al. Poly(fumaric-co-sebacic) microspheres as oral drug delivery systems. , 1996, Biotechnology and bioengineering.
[83] H. Florey. The secretion and function of intestinal mucus. , 1962, Gastroenterology.
[84] V. Khutoryanskiy,et al. POZylation: a new approach to enhance nanoparticle diffusion through mucosal barriers. , 2015, Nanoscale.
[85] Samuel K. Lai,et al. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses , 2009, Proceedings of the National Academy of Sciences.
[86] Dandan Liu,et al. Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate. , 2017, International journal of biological macromolecules.
[87] L. Kaminskas,et al. Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance. , 2011, Journal of pharmaceutical sciences.
[88] Hongming Chen,et al. Mucus-penetrating nanoparticles made with "mucoadhesive" poly(vinyl alcohol). , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[89] Justin Hanes,et al. Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus. , 2011, Angewandte Chemie.
[90] Alexander V Kabanov,et al. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[91] Ewen King-Smith,et al. The thickness of the tear film , 2004, Current eye research.
[92] A. Herp,et al. Studies on the isolation and composition of human ocular mucin. , 1988, Experimental eye research.
[93] N. Willenbacher,et al. Size-Limited Penetration of Nanoparticles into Porcine Respiratory Mucus after Aerosol Deposition. , 2016, Biomacromolecules.
[94] Haruki Nakamura,et al. Nature of the charge distribution in proteins , 1981, Nature.
[95] P. Mugwe,et al. Mucociliary Clearance Time in Patients with and without Rhinitis , 2014 .
[96] J. Mascola,et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies , 2000, Nature Medicine.
[97] J M Samet,et al. The role of airway mucus in pulmonary toxicology. , 1994, Environmental health perspectives.
[98] M. Qiao,et al. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[99] J. Sheehan,et al. Electron microscopy of cervical, gastric and bronchial mucus glycoproteins. , 1986, The Biochemical journal.
[100] P. Artursson,et al. Biopharmaceutics of Microparticulate Drug Carriers , 1987, Annals of the New York Academy of Sciences.
[101] K. Popat,et al. Conformational studies of covalently grafted poly(ethylene glycol) on modified solid matrices using X-ray photoelectron spectroscopy. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[102] Jenn‐Shing Chen,et al. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications. , 2009, Biomaterials.
[103] R. Jain,et al. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins , 2016, Drug Delivery and Translational Research.
[104] Jayanth Panyam,et al. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.
[105] Harendra Arora,et al. Influenza-binding antibodies immobilise influenza viruses in fresh human airway mucus , 2017, European Respiratory Journal.
[106] J. S. Suk,et al. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine. , 2011, Nanomedicine.
[107] Samuel K. Lai,et al. Altering Mucus Rheology to “Solidify” Human Mucus at the Nanoscale , 2009, PloS one.
[108] J. Hanes,et al. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[109] Benjamin C. Tang,et al. N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[110] J. Irache,et al. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. , 1998, Advanced drug delivery reviews.
[111] J. Pearson,et al. Upper Airway Mucin Gene Expression: A Review , 2007, The Laryngoscope.
[112] J. Sheehan,et al. Structure and macromolecular properties of mucus glycoproteins. , 1988, Monographs in allergy.
[113] J Woodley,et al. Bioadhesion: new possibilities for drug administration? , 2001, Clinical pharmacokinetics.
[114] M. Breunig,et al. Influence of PEGylation on nanoparticle mobility in different models of the extracellular matrix. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[115] Raimo Hartmann,et al. Surface Functionalization of Nanoparticles with Polyethylene Glycol: Effects on Protein Adsorption and Cellular Uptake. , 2015, ACS nano.
[116] A. Hoffman,et al. Mucoadhesive drug carriers based on complexes of poly(acrylic acid) and PEGylated drugs having hydrolysable PEG-anhydride-drug linkages. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[117] O. Mert,et al. Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus. , 2011, Biomaterials.
[118] H. Fessi,et al. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. , 2005, Critical reviews in therapeutic drug carrier systems.
[119] J. Hanes,et al. The microstructure and bulk rheology of human cervicovaginal mucus are remarkably resistant to changes in pH. , 2013, Biomacromolecules.
[120] Justin Hanes,et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus , 2007, Proceedings of the National Academy of Sciences.
[121] Benjamin S Schuster,et al. Particle tracking in drug and gene delivery research: State-of-the-art applications and methods. , 2015, Advanced drug delivery reviews.
[122] L. Medina-Kauwe,et al. Intracellular trafficking of nonviral vectors , 2005, Gene Therapy.
[123] N. Joo,et al. Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na+] and pH but elevated viscosity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[124] Donald E. Chickering,et al. Biologically erodable microspheres as potential oral drug delivery systems , 1997, Nature.
[125] Robert Langer,et al. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. , 2009, Biomaterials.
[126] H. Florey. Mucin and the protection of the body. , 1955, Proceedings of the Royal Society of London. Series B, Biological sciences.
[127] N. Škalko-Basnet,et al. Mucoadhesive liposomal delivery systems: the choice of coating material , 2011, Drug development and industrial pharmacy.
[128] Robert Langer,et al. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile , 2012, Science Translational Medicine.
[129] Michael P Boyle,et al. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. , 2009, Biomaterials.
[130] Jesse V Jokerst,et al. Nanoparticle PEGylation for imaging and therapy. , 2011, Nanomedicine.
[131] M. N. Jones,et al. Effect of grafted polyethylene glycol (PEG) on the size, encapsulation efficiency and permeability of vesicles. , 2000, Biochimica et biophysica acta.
[132] J. Kreuter,et al. Quantitative and microautoradiographic study on mouse intestinal distribution of polycyanoacrylate nanoparticles , 1989 .
[133] Benjamin C. Tang,et al. Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation , 2017, Science Advances.
[134] R. Carrier,et al. Size selectivity of intestinal mucus to diffusing particulates is dependent on surface chemistry and exposure to lipids , 2015, Journal of drug targeting.
[135] N. Peppas,et al. Enhanced hydrogel adhesion by polymer interdiffusion: use of linear poly(ethylene glycol) as an adhesion promoter. , 1997, Journal of biomaterials science. Polymer edition.
[136] G. Russell-Jones,et al. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. , 1999, International journal of pharmaceutics.
[137] J. Kaunitz,et al. Barrier function of the gastric mucus gel. , 1995, The American journal of physiology.
[138] A. Bernkop‐Schnürch. Thiomers: a new generation of mucoadhesive polymers. , 2005, Advanced drug delivery reviews.
[139] Clive G. Wilson,et al. Treatment of diseases of the eye with mucoadhesive delivery systems , 1993 .
[140] Wei Tao,et al. Enhanced Oral Delivery of Protein Drugs Using Zwitterion-Functionalized Nanoparticles to Overcome both the Diffusion and Absorption Barriers. , 2016, ACS applied materials & interfaces.
[141] T. Gerken,et al. Role of glycosylation on the conformation and chain dimensions of O-linked glycoproteins: light-scattering studies of ovine submaxillary mucin. , 1989, Biochemistry.
[142] Hongming Chen,et al. Enhanced pulmonary delivery of fluticasone propionate in rodents by mucus-penetrating nanoparticles. , 2016, International journal of pharmaceutics.
[143] B. Hirst,et al. Lectin-mediated mucosal delivery of drugs and microparticles. , 2000, Advanced drug delivery reviews.
[144] S. Souto,et al. esign of cationic lipid nanoparticles for ocular delivery : evelopment , characterization and cytotoxicity , 2013 .
[145] D. Wirtz,et al. Enhanced Viscoelasticity of Human Cystic Fibrotic Sputum Correlates with Increasing Microheterogeneity in Particle Transport* , 2003, Journal of Biological Chemistry.
[146] Zhirong Zhang,et al. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. , 2015, ACS nano.
[147] Scott A. McKinley,et al. Using Computational Modeling To Optimize the Design of Antibodies That Trap Viruses in Mucus. , 2016, ACS infectious diseases.
[148] B. Tirosh,et al. Migration of adhesive and nonadhesive particles in the rat intestine under altered mucus secretion conditions. , 1998, Journal of pharmaceutical sciences.
[149] J. Hanes,et al. Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[150] Gert Storm,et al. Sheddable Coatings for Long-Circulating Nanoparticles , 2007, Pharmaceutical Research.
[151] J. Chern,et al. Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM. , 1999, Bioconjugate chemistry.
[152] Elizabeth Nance,et al. Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[153] Xue Li,et al. Micro- and nano-carrier systems: The non-invasive and painless local administration strategies for disease therapy in mucosal tissues. , 2017, Nanomedicine : nanotechnology, biology, and medicine.
[154] B. Hirst,et al. M-Cell Surface β1 Integrin Expression and Invasin-Mediated Targeting of Yersinia pseudotuberculosis to Mouse Peyer’s Patch M Cells , 1998, Infection and Immunity.
[155] Jin-Zhi Du,et al. Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery. , 2012, ACS nano.
[156] J. Cryan,et al. A click chemistry route to 2-functionalised PEGylated and cationic β-cyclodextrins: co-formulation opportunities for siRNA delivery. , 2012, Organic & biomolecular chemistry.
[157] E. Wagner,et al. Design and gene delivery activity of modified polyethylenimines. , 2001, Advanced drug delivery reviews.
[158] Yoon Yeo,et al. Recent advances in stealth coating of nanoparticle drug delivery systems. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[159] Alexander T. Florence,et al. Enhanced Oral Uptake of Tomato Lectin-Conjugated Nanoparticles in the Rat , 1997, Pharmaceutical Research.
[160] L. Holm,et al. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[161] J. Rossen,et al. The MUC family: an obituary. , 2002, Trends in biochemical sciences.
[162] J. Vergnes,et al. Fractionation and partial characterization of macromolecular components from human ocular mucus. , 1983, Experimental eye research.
[163] A. Kros,et al. The chemical modification of liposome surfaces via a copper-mediated [3 + 2] azide-alkyne cycloaddition monitored by a colorimetric assay. , 2006, Chemical communications.
[164] H. Takeuchi,et al. In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[165] I. Pali-Schöll,et al. Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[166] Daniel W. Pack,et al. Design and development of polymers for gene delivery , 2005, Nature Reviews Drug Discovery.
[167] S. Davis,et al. In vitro evaluation of the mucoadhesive properties of chitosan microspheres , 1998 .
[168] Jung Soo Suk,et al. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier. , 2008, Angewandte Chemie.
[169] S. Lai,et al. Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation. , 2014, Molecular pharmaceutics.
[170] Robert Langer,et al. Lectin-bearing Polymerized Liposomes as Potential Oral Vaccine Carriers , 1996, Pharmaceutical Research.
[171] Claus-Michael Lehr,et al. An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop , 1991 .
[172] K. Whaley,et al. Antibody diffusion in human cervical mucus. , 1994, Biophysical journal.
[173] G. Giammona,et al. Pegylated Polyaspartamide-Polylactide-Based Nanoparticles Penetrating Cystic Fibrosis Artificial Mucus. , 2016, Biomacromolecules.
[174] Kyung‐Yeol Lee,et al. Mucosal Immune System and M Cell-targeting Strategies for Oral Mucosal Vaccination , 2012, Immune network.
[175] Gunnar C. Hansson,et al. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host–microbial interactions , 2010, Proceedings of the National Academy of Sciences.
[176] Benjamin C. Tang,et al. Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus , 2012, Science Translational Medicine.
[177] D. Burton,et al. Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers , 2009, PLoS pathogens.
[178] M. A. Arangoa,et al. Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[179] G. Woodworth,et al. Nanoparticle diffusion in respiratory mucus from humans without lung disease. , 2013, Biomaterials.
[180] James E Bear,et al. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. , 2012, Nano letters.
[181] M D Donovan,et al. Drug transfer through mucus. , 2001, Advanced drug delivery reviews.
[182] Samuel K Lai,et al. Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population. , 2016, Analytical chemistry.
[183] Y. Barenholz,et al. Differential Adhesion of Normal and Inflamed Rat Colonic Mucosa by Charged Liposomes , 2004, Pharmaceutical Research.
[184] H. Florey. The Croonian Lecture: Mucin and the protection of the body , 1955, Proceedings of the Royal Society of London. Series B - Biological Sciences.
[185] G. Ponchel,et al. Gastrointestinal Transit and Mucoadhesion of Colloidal Suspensions of Lycopersicon Esculentum L. and Lotus Tetragonolobus Lectin-PLA Microsphere Conjugates in Rats , 2001, Pharmaceutical Research.
[186] D. Quintanar-Guerrero,et al. In vitro evaluation of the bioadhesive properties of hydrophobic polybasic gels containing N,N-dimethylaminoethyl methacrylate-co-methyl methacrylate. , 2001, Biomaterials.
[187] O. Farokhzad,et al. Polymeric nanoparticle drug delivery technologies for oral delivery applications , 2015, Expert opinion on drug delivery.
[188] U. Ulmsten,et al. Isolation and characterization of human cervical-mucus glycoproteins. , 1983, The Biochemical journal.
[189] Leaf Huang,et al. Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. , 2009, Biochimica et biophysica acta.
[190] A. Kim,et al. Non-specific binding and steric hindrance thresholds for penetration of particulate drug carriers within tumor tissue. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[191] C. Valenta. The use of mucoadhesive polymers in vaginal delivery. , 2005, Advanced drug delivery reviews.
[192] Rihe Liu,et al. The smart targeting of nanoparticles. , 2013, Current pharmaceutical design.
[193] R. Gurny,et al. Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. , 1998, Advanced drug delivery reviews.
[194] D. Wei,et al. Impact of Large Aggregated Uricases and PEG Diol on Accelerated Blood Clearance of PEGylated Canine Uricase , 2012, PloS one.
[195] Xiaoqun Gong,et al. Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo. , 2015, ACS nano.
[196] A. Verkman,et al. Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. , 2003, American journal of physiology. Cell physiology.
[197] J. Hanes,et al. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. , 2009, Advanced drug delivery reviews.
[198] Juan B. Blanco-Canosa,et al. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. , 2011, ACS nano.
[199] J. Irache,et al. In vitro study of lectin-latex conjugates for specific bioadhesion , 1994 .
[200] R. Cone,et al. Barrier properties of mucus. , 2009, Advanced drug delivery reviews.
[201] R. Langer,et al. Nanomedicine: developing smarter therapeutic and diagnostic modalities. , 2006, Advanced drug delivery reviews.
[202] Y. Huang,et al. Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[203] Feng Zan,et al. Colloidal stability of gold nanoparticles modified with thiol compounds: bioconjugation and application in cancer cell imaging. , 2012, Langmuir : the ACS journal of surfaces and colloids.
[204] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.
[205] Y. Yoshioka,et al. Intravenous administration of polyethylene glycol-coated (PEGylated) proteins and PEGylated adenovirus elicits an anti-PEG immunoglobulin M response. , 2012, Biological & pharmaceutical bulletin.
[206] Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers. , 2013, Angewandte Chemie.
[207] Claus-Michael Lehr,et al. Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa , 2001, Pharmaceutical Research.
[208] Jeffrey A. Hubbell,et al. Materials engineering for immunomodulation , 2009, Nature.
[209] Patrick J. Sinko,et al. Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin , 1997 .
[210] S. Ostad,et al. Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation , 2011, International journal of nanomedicine.
[211] Min Liu,et al. Lipid nanovehicles with adjustable surface properties for overcoming multiple barriers simultaneously in oral administration. , 2017, International journal of pharmaceutics.
[212] J. S. Suk,et al. MR image‐guided delivery of cisplatin‐loaded brain‐penetrating nanoparticles to invasive glioma with focused ultrasound , 2017, Journal of controlled release : official journal of the Controlled Release Society.